Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 157 - 168 of 438
General Hepatology
Online course: EASL–EFSUMB Ultrasound of the liver

Online course: EASL–EFSUMB Ultrasound of the liver

Online Courses
View
Basic Science
Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

Podcasts
View
Liver Tumours
Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz
View
General Hepatology
Online course: EASL–ESPEN Nutrition in liver disease

Online course: EASL–ESPEN Nutrition in liver disease

Online Courses
View
General Hepatology
EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

On-demand Webinars
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

Podcasts
View
General Hepatology
EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

Podcasts
View
Metabolism, Alcohol & Toxicity
Quiz: A quarter of the global adult population is estimated to have non-alcoholic fatty liver disease (NAFLD)

Quiz: A quarter of the global adult population is estimated to have non-alcoholic fatty liver disease (NAFLD)

Quiz
View

EASL Studio S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

Description

Collaborations are key in achieving scientific progress. The European Horizon COST Actions provide great opportunities to build, grant, and/or participate in pan-European collaborations in multidisciplinary topics, including liver diseases.

This EASL Studio:

  • Provides you with information about the COST Action programme.
  • Discusses the structure of the drug-induced liver injury (DILI) and cholangiocarcinoma (CCA) working groups.
  • Highlights the potential for collaborative work within this programme.

Faculty

  • Prof. Jesús Bañales (Moderator)
  • Prof. Raul Andrade (Faculty)
  • Dr Chiara Braconi (Faculty)
  • Prof. Vincenzo Cardinale (Faculty)

Related episodes

  • S4E13: EASL-EF CLIF and EU Grants: Exploring novel mechanisms and treatment of chronic liver failure
  • S4E2: YI Choice: How to build consortia and registries

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Log in to post comments
General Hepatology
EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio Podcast S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

Podcasts
View
General Hepatology
EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast S4 Special Edition: Promoting Liver Health: An urgent call for action at WHO

Podcasts
View
Displaying 157 - 168 of 438